We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$141M
AUM Growth
+$141M
Cap. Flow
+$1.45M
Cap. Flow %
1.02%
Top 10 Hldgs %
58.5%
Holding
60
New
2
Increased
18
Reduced
34
Closed
2

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$284K
2
ILMN icon
Illumina
ILMN
+$242K
3
SBUX icon
Starbucks
SBUX
+$144K
4
AAPL icon
Apple
AAPL
+$113K
5
CELG
Celgene Corp
CELG
+$104K

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Technology 29.58%
3 Consumer Discretionary 20.44%
4 Communication Services 7.21%
5 Energy 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$15.6M 11.04%
671,828
-5,296
-0.8% -$113K
ILMN icon
2
Illumina
ILMN
$28.7B
$11.9M 8.45%
68,761
-1,619
-2% -$242K
GILD icon
3
Gilead Sciences
GILD
$162B
$9.1M 6.43%
109,699
-138
-0.1% -$10.7K
CELG
4
DELISTED
Celgene Corp
CELG
$8.79M 6.22%
102,324
-1,366
-1% -$104K
CTSH icon
5
Cognizant
CTSH
$22.3B
$7.51M 5.31%
153,513
-1,255
-0.8% -$61.2K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$3.99T
$7.07M 5%
244,570
-2,994
-1% -$81.2K
ISRG icon
7
Intuitive Surgical
ISRG
$128B
$6.6M 4.67%
144,180
-873
-0.6% -$38.5K
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$5.77M 4.08%
36,948
-290
-0.8% -$45.8K
VMW
9
DELISTED
VMware, Inc
VMW
$5.69M 4.03%
58,779
-550
-0.9% -$53.5K
CAVM
10
DELISTED
Cavium, Inc.
CAVM
$4.6M 3.26%
92,721
-1,185
-1% -$54.5K
VIPS icon
11
Vipshop
VIPS
$7.08B
$4.28M 3.03%
228,100
+1,940
+0.9% +$31.1K
LULU icon
12
lululemon athletica
LULU
$13.4B
$4.17M 2.95%
102,886
-630
-0.6% -$28.7K
QCOM icon
13
Qualcomm
QCOM
$179B
$3.96M 2.8%
49,946
-3,573
-7% -$284K
SBUX icon
14
Starbucks
SBUX
$118B
$3.37M 2.39%
87,132
-3,968
-4% -$144K
BKNG icon
15
Booking.com
BKNG
$145B
$3.34M 2.36%
69,400
+100
+0.1% +$4.8K
AMZN icon
16
Amazon
AMZN
$2.49T
$3.13M 2.21%
192,460
+320
+0.2% +$5.06K
ULTA icon
17
Ulta Beauty
ULTA
$20.7B
$3.07M 2.17%
33,616
+145
+0.4% +$13.1K
PCYC
18
DELISTED
PHARMACYCLICS INC
PCYC
$2.55M 1.81%
28,449
+23,649
+493% +$2.22M
NPSP
19
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$2.49M 1.76%
75,460
+1,849
+3% +$53.4K
BIDU icon
20
Baidu
BIDU
$35.8B
$2.44M 1.73%
13,062
-57
-0.4% -$9.33K
MELI icon
21
Mercado Libre
MELI
$92.3B
$2.36M 1.67%
24,692
+207
+0.8% +$18.1K
POWI icon
22
Power Integrations
POWI
$3.53B
$2.27M 1.6%
78,844
-2,850
-3% -$79.7K
NDLS icon
23
Noodles & Co
NDLS
$84M
$2.08M 1.47%
7,569
+290
+4% +$79.6K
MDVN
24
DELISTED
MEDIVATION, INC.
MDVN
$2.05M 1.45%
53,268
+2,460
+5% +$82.9K
WOLF icon
25
Wolfspeed
WOLF
$1.24B
$1.89M 1.34%
37,883
-345
-0.9% -$17.1K

Similar funds

Bender Robert & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Bender Robert & Associates held 60 positions worth $141M, up 94,692% from $149K the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bender Robert & Associates's Q2 2014 filing shows 2 new, 18 increased, 34 reduced and 2 closed positions. Its largest new stake was American Express: 2,180 shares worth $207K. The largest sale was Qualcomm, an estimated $284K.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Bender Robert & Associates's largest Q2 2014 buy was American Express: 2,180 shares worth $207K.
  • Bender Robert & Associates added most to PHARMACYCLICS INC in Q2 2014, an estimated $2.22M increase.
  • Bender Robert & Associates's biggest Q2 2014 reduction was Qualcomm, cutting an estimated $284K.
  • Bender Robert & Associates fully exited BROADCOM CORP CL-A in Q2 2014, selling an estimated $219.
  • Bender Robert & Associates's ten largest holdings make up 58% of its $141M portfolio in Q2 2014.
  • Bender Robert & Associates opened 2 new positions and closed 2 in Q2 2014.
  • Bender Robert & Associates's portfolio value rose 94,692% quarter-over-quarter to $141M.

Based on Bender Robert & Associates's 13F filing for Q2 2014, filed 4 Aug 2014.